MCCULLOCH KEVIN (See Remarks) reported 1 transaction at XERIS BIOPHARMA HOLDINGS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 1/7/2025ACC: 0001867096-25-000014
Officer· See Remarks
Since Mar 2026
-24.50K
Net shares
Net seller
$88.4K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
24.50K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−24.50K
Price / share
$3.61
Trade value
$88.45K
% of position
1.5%
1/3/2025
1.60M→1.58M
Total
Net shares
−24.50K
Net value
-$88.45K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/3/2025 | F · Tax Withholding | −24.50K | $3.61 | $88.45K | 1.5% | 1.60M | 1.58M |
| Total | −24.50K | -$88.45K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned25K
Common Stock
IndirectShares owned2K
Total
27K indirect27K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 25K | Indirect |
| Common Stock | 2K | Indirect |
| Total | 27K | 27K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported